Suchergebnisse - Alexander N. Shoushtari

Treffer weiter einschränken
  1. 1
    Tumor-Infiltrating Lymphocyte Therapy for Melanoma and Other Solid Tumors: Looking Back, Yet Moving Forward

    Tumor-Infiltrating Lymphocyte Therapy for Melanoma and Other Solid Tumors: Looking Back, Yet Moving Forward von Alexander N. Shoushtari, Daniel J. Powell

    Veröffentlicht 2025
    Volltext
    Revisão
    Zu den Favoriten
    Gespeichert in:
  2. 2
    Vascular Endothelial Growth Factor-C and C-C Chemokine Receptor 7 in Tumor Cell–Lymphatic Cross-talk Promote Invasive Phenotype

    Vascular Endothelial Growth Factor-C and C-C Chemokine Receptor 7 in Tumor Cell–Lymphatic Cross-talk Promote Invasive Phenotype von Amine Issa, Thomas X. Le, Alexander N. Shoushtari, Jacqueline D. Shields, Melody A. Swartz

    Veröffentlicht 2008
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  3. 3
    Primary and Metastatic Melanoma With NTRK Fusions

    Primary and Metastatic Melanoma With NTRK Fusions von Cecilia Lezcano, Alexander N. Shoushtari, Charlotte E. Ariyan, Travis J. Hollmann, Klaus J. Busam

    Veröffentlicht 2018
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  4. 4
    Safety and efficacy of ipilimumab to treat advanced melanoma in the setting of liver transplantation

    Safety and efficacy of ipilimumab to treat advanced melanoma in the setting of liver transplantation von Rita E Morales, Alexander N. Shoushtari, Michelle M. Walsh, Priya Grewal, Evan J. Lipson, Richard D. Carvajal

    Veröffentlicht 2015
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  5. 5
    Combined immunotherapy and radiation for treatment of mucosal melanomas of the lower genital tract

    Combined immunotherapy and radiation for treatment of mucosal melanomas of the lower genital tract von Maria B. Schiavone, Vance Broach, Alexander N. Shoushtari, Richard D. Carvajal, Kaled M. Alektiar, Marisa Kollmeier, Nadeem R. Abu‐Rustum, Mario M. Leitão

    Veröffentlicht 2016
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  6. 6
    Pilot Study of ONCOS-102 and Pembrolizumab: Remodeling of the Tumor Microenvironment and Clinical Outcomes in Anti–PD-1–Resistant Advanced Melanoma

    Pilot Study of ONCOS-102 and Pembrolizumab: Remodeling of the Tumor Microenvironment and Clinical Outcomes in Anti–PD-1–Resistant Advanced Melanoma von Alexander N. Shoushtari, Anthony J. Olszanski, Marta Nyakas, Thomas J. Hornyak, Jedd D. Wolchok, Victor Levitsky, Łukasz Kuryk, Thomas B. Hansen, Magnus Jäderberg

    Veröffentlicht 2022
    Volltext Volltext
    Carta
    Zu den Favoriten
    Gespeichert in:
  7. 7
    Localized sinonasal mucosal melanoma: Outcomes and associations with stage, radiotherapy, and positron emission tomography response

    Localized sinonasal mucosal melanoma: Outcomes and associations with stage, radiotherapy, and positron emission tomography response von Robert M. Samstein, Richard D. Carvajal, Michael A. Postow, Margaret K. Callahan, Alexander N. Shoushtari, Snehal G. Patel, Nancy Y. Lee, Christopher A. Barker

    Veröffentlicht 2016
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  8. 8
    Measuring Toxic Effects and Time to Treatment Failure for Nivolumab Plus Ipilimumab in Melanoma

    Measuring Toxic Effects and Time to Treatment Failure for Nivolumab Plus Ipilimumab in Melanoma von Alexander N. Shoushtari, Claire F. Friedman, Pedram Navid-Azarbaijani, Michael A. Postow, Margaret K. Callahan, Parisa Momtaz, Katherine S. Panageas, Jedd D. Wolchok, Paul B. Chapman

    Veröffentlicht 2017
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  9. 9
    Tolerance and efficacy of BRAF plus MEK inhibition in patients with melanoma who previously have received programmed cell death protein 1‐based therapy

    Tolerance and efficacy of BRAF plus MEK inhibition in patients with melanoma who previously have received programmed cell death protein 1‐based therapy von Karim R. Saab, Meghan J. Mooradian, Daniel Wang, Jeewon Chon, Cathy Yi Xia, Angelica Bialczak, Kelly Abbate, Alexander M. Menzies, Douglas B. Johnson, Ryan J. Sullivan, Alexander N. Shoushtari

    Veröffentlicht 2018
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  10. 10
    Thinking Critically About Classifying Adverse Events: Incidence of Pancreatitis in Patients Treated With Nivolumab + Ipilimumab

    Thinking Critically About Classifying Adverse Events: Incidence of Pancreatitis in Patients Treated With Nivolumab + Ipilimumab von Claire F. Friedman, Varina R. Clark, Andrew V. Raikhel, Tim Barz, Alexander N. Shoushtari, Parisa Momtaz, Margaret K. Callahan, Jedd D. Wolchok, Paul B. Chapman, Matthew D. Hellmann, Michael A. Postow

    Veröffentlicht 2016
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  11. 11
    Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma

    Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma von Megan H. Pollack, Allison Betof Warner, Helen Dearden, K. Rapazzo, Ian Valentine, Andrew S. Brohl, Kristin Kathleen Ancell, Georgina V. Long, Alexander M. Menzies, Zeynep Eroglu, Douglas B. Johnson, Alexander N. Shoushtari

    Veröffentlicht 2017
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  12. 12
    Treatment of advanced melanoma - A changing landscape

    Treatment of advanced melanoma - A changing landscape von Adriana Hepner, Alessandra Corte Real Salgues, Carlos A. dos Anjos, Marina Sahade, Veridiana Pires de Camargo, Bernardo Garicochea, Alexander N. Shoushtari, Michael A. Postow, Gustavo dos Santos Fernandes, Rodrigo Ramella Munhoz

    Veröffentlicht 2017
    Volltext Volltext
    Revisão
    Zu den Favoriten
    Gespeichert in:
  13. 13
    Long-Term Outcomes and Responses to Retreatment in Patients With Melanoma Treated With PD-1 Blockade

    Long-Term Outcomes and Responses to Retreatment in Patients With Melanoma Treated With PD-1 Blockade von Allison Betof Warner, Jessica Palmer, Alexander N. Shoushtari, Debra A. Goldman, Katherine S. Panageas, Sara A. Hayes, Raazi Bajwa, Parisa Momtaz, Margaret K. Callahan, Jedd D. Wolchok, Michael A. Postow, Paul B. Chapman

    Veröffentlicht 2020
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  14. 14
    Prevalence of tumor-infiltrating lymphocytes and PD-L1 expression in the soft tissue sarcoma microenvironment

    Prevalence of tumor-infiltrating lymphocytes and PD-L1 expression in the soft tissue sarcoma microenvironment von Sandra P. D’Angelo, Alexander N. Shoushtari, Narasimhan P. Agaram, Deborah Kuk, Li‐Xuan Qin, Richard D. Carvajal, Mark A. Dickson, Mrinal M. Gounder, Mary Louise Keohan, Gary K. Schwartz, William D. Tap

    Veröffentlicht 2014
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  15. 15
    Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma

    Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma von Amanda R. Moore, Emilie Ceraudo, Jessica Sher, Youxin Guan, Alexander N. Shoushtari, Matthew T. Chang, Jenny Q. Zhang, Edward Walczak, Manija A. Kazmi, Barry S. Taylor, Thomas Huber, Ping Chi, Thomas P. Sakmar, Yu Chen

    Veröffentlicht 2016
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  16. 16
    Peripheral blood clinical laboratory variables associated with outcomes following combination nivolumab and ipilimumab immunotherapy in melanoma

    Peripheral blood clinical laboratory variables associated with outcomes following combination nivolumab and ipilimumab immunotherapy in melanoma von Samuel Rosner, Erica Kwong, Alexander N. Shoushtari, Claire F. Friedman, Allison Betof Warner, Mary Sue Brady, Daniel G. Coit, Margaret K. Callahan, Jedd D. Wolchok, Paul B. Chapman, Katherine S. Panageas, Michael A. Postow

    Veröffentlicht 2018
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  17. 17
    Survival Outcomes After Metastasectomy in Melanoma Patients Categorized by Response to Checkpoint Blockade

    Survival Outcomes After Metastasectomy in Melanoma Patients Categorized by Response to Checkpoint Blockade von Danielle M. Bello, Katherine S. Panageas, Travis J. Hollmann, Alexander N. Shoushtari, Parisa Momtaz, Paul B. Chapman, Michael A. Postow, Margaret K. Callahan, Jedd D. Wolchok, Mary S. Brady, Daniel G. Coit, Charlotte E. Ariyan

    Veröffentlicht 2019
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  18. 18
    Eosinophilic Fasciitis Following Checkpoint Inhibitor Therapy: Four Cases and a Review of Literature

    Eosinophilic Fasciitis Following Checkpoint Inhibitor Therapy: Four Cases and a Review of Literature von Karmela K Chan, Cynthia M. Magro, Alexander N. Shoushtari, Charles M. Rudin, Veronica Rotemberg, Anthony Rossi, Cecilia Lezcano, John A. Carrino, David Fernández, Michael A. Postow, Arlyn Apollo, Mario E. Lacouture, Anne R. Bass

    Veröffentlicht 2019
    Volltext Volltext
    Revisão
    Zu den Favoriten
    Gespeichert in:
  19. 19
    GNA11 Q209L Mouse Model Reveals RasGRP3 as an Essential Signaling Node in Uveal Melanoma

    GNA11 Q209L Mouse Model Reveals RasGRP3 as an Essential Signaling Node in Uveal Melanoma von Amanda R. Moore, Leili Ran, Youxin Guan, Jessica Sher, Tyler D. Hitchman, Jenny Q. Zhang, Catalina Hwang, Edward G. Walzak, Alexander N. Shoushtari, Sébastien Monette, Rajmohan Murali, Thomas Wiesner, Klaus Griewank, Ping Chi, Yu Chen

    Veröffentlicht 2018
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  20. 20
    Myocarditis Surveillance in Patients with Advanced Melanoma on Combination Immune Checkpoint Inhibitor Therapy: The Memorial Sloan Kettering Cancer Center Experience

    Myocarditis Surveillance in Patients with Advanced Melanoma on Combination Immune Checkpoint Inhibitor Therapy: The Memorial Sloan Kettering Cancer Center Experience von Katherine Lee Chuy, Evangelos K. Oikonomou, Michael A. Postow, Margaret K. Callahan, Paul B. Chapman, Alexander N. Shoushtari, Tomas G. Neilan, Michael G. Fradley, Lakshmi V. Ramanathan, Jedd D. Wolchok, Richard M. Steingart, Dipti Gupta

    Veröffentlicht 2019
    Volltext Volltext
    Carta
    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: